Russian Health Ministry issues permit for post-registration trials of CoviVac vaccine

MOSCOW. June 8 (Interfax) - The Chumakov Center has received a permit for post-registration trials of its vaccine against coronavirus, according to the Russian Health Ministry's register of clinical trials.

The CoviVac vaccine's efficacy, immunogenicity and safety will be tested on healthy volunteers aged 18-60.

Trials will take place in 16 medical centers in Moscow, St. Petersburg, Kirov, Chelyabinsk, the Belgorod, Orenburg and Kursk regions, and Tatarstan.